Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-06

FDA Approved: BUDESONIDE INHALATION SUSPENSION — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for budesonide inhalation suspension from Cipla USA Inc. This approval adds or modifies the product labeling/indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide Inhalation Suspension (budesonide)

Snippet

SUPPL AP for BUDESONIDE INHALATION SUSPENSION (BUDESONIDE)